LoginSignup
XLS

Xlife Sciences

Stock
Stock
ISIN: CH0461929603
Ticker: XLS
CH0461929603
XLS

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Xlife Sciences is $92.56M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Xlife Sciences's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.653. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Xlife Sciences's stock, with a consensus target price of $38.27. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Xlife Sciences reported a revenue of $1.04M.
Xlife Sciences's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$4.89M. EBITDA measures the company's overall financial performance.
Xlife Sciences has a free cash flow of -$295.38K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
The free float of Xlife Sciences is 2.99M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$92.56M
EPS (TTM) 
$6.653
Free Float 
2.99M
Revenue (TTM) 
$1.04M
EBITDA (TTM) 
-$4.89M
Free Cashflow (TTM) 
-$295.38K

Pricing

52W span
$15.37$33.84

Analyst Ratings

The price target is $38.27 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company was founded in 2019 and is headquartered in Zurich, Switzerland.

Industries
Miscellaneous Commercial Services
Sector
Financials

Identifier

ISIN
CH0461929603
Primary Ticker
XLS
Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin